Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome

PURPOSE: Antitumor activity of cancer immunotherapies may elicit immune responses to nontargeted (secondary) tumor antigens, or antigen spread. We evaluated humoral antigen spread after treatment with sipuleucel-T, an immunotherapy for asymptomatic or minimally symptomatic metastatic castration-resi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Cancer Res
Päätekijät: GuhaThakurta, Debraj, Sheikh, Nadeem A., Fan, Li-Qun, Kandadi, Harini, Meagher, T. Craig, Hall, Simon J., Kantoff, Philip W., Higano, Celestia S., Small, Eric J., Gardner, Thomas A., Bailey, Kate, Vu, Tuyen, DeVries, Todd, Whitmore, James B., Frohlich, Mark W., Trager, James B., Drake, Charles G.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4868054/
https://ncbi.nlm.nih.gov/pubmed/25649018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-2334
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia